TY - JOUR
T1 - Measurement of pulsatile insulin secretion
T2 - Rationale and methodology
AU - Laurenti, Marcello C.
AU - Matveyenko, Aleksey
AU - Vella, Adrian
N1 - Funding Information:
Funding: The authors acknowledge the support of the Mayo Clinic General Clinical Research Center (DK TR000135) for the conduct of our experiments cited in this review. Vella is supported by DK78646, DK116231 and DK126206.
Funding Information:
The authors acknowledge the support of the Mayo Clinic General Clinical Research Center (DK TR000135) for the conduct of our experiments cited in this review. Vella is supported by DK78646, DK116231 and DK126206.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/7
Y1 - 2021/7
N2 - Pancreatic β-cells are responsible for the synthesis and exocytosis of insulin in response to an increase in circulating glucose. Insulin secretion occurs in a pulsatile manner, with oscillatory pulses superimposed on a basal secretion rate. Insulin pulses are a marker of β-cell health, and secretory parameters, such as pulse amplitude, time interval and frequency distribution, are impaired in obesity, aging and type 2 diabetes. In this review, we detail the mechanisms of insulin production and β-cell synchronization that regulate pulsatile insulin secretion, and we discuss the challenges to consider when measuring fast oscillatory secretion in vivo. These include the anatomical difficulties of measuring portal vein insulin noninvasively in humans before the hormone is extracted by the liver and quickly removed from the circulation. Peripheral concentrations of insulin or C-peptide, a peptide cosecreted with insulin, can be used to estimate their secretion profile, but mathematical deconvolution is required. Parametric and nonparametric approaches to the deconvolution problem are evaluated, alongside the assumptions and trade-offs required for their application in the quantifi-cation of unknown insulin secretory rates from known peripheral concentrations. Finally, we discuss the therapeutical implication of targeting impaired pulsatile secretion and its diagnostic value as an early indicator of β-cell stress.
AB - Pancreatic β-cells are responsible for the synthesis and exocytosis of insulin in response to an increase in circulating glucose. Insulin secretion occurs in a pulsatile manner, with oscillatory pulses superimposed on a basal secretion rate. Insulin pulses are a marker of β-cell health, and secretory parameters, such as pulse amplitude, time interval and frequency distribution, are impaired in obesity, aging and type 2 diabetes. In this review, we detail the mechanisms of insulin production and β-cell synchronization that regulate pulsatile insulin secretion, and we discuss the challenges to consider when measuring fast oscillatory secretion in vivo. These include the anatomical difficulties of measuring portal vein insulin noninvasively in humans before the hormone is extracted by the liver and quickly removed from the circulation. Peripheral concentrations of insulin or C-peptide, a peptide cosecreted with insulin, can be used to estimate their secretion profile, but mathematical deconvolution is required. Parametric and nonparametric approaches to the deconvolution problem are evaluated, alongside the assumptions and trade-offs required for their application in the quantifi-cation of unknown insulin secretory rates from known peripheral concentrations. Finally, we discuss the therapeutical implication of targeting impaired pulsatile secretion and its diagnostic value as an early indicator of β-cell stress.
KW - C-peptide kinetics
KW - Hormone deconvolution
KW - Insulin pulses
KW - Pulsatile insulin secretion
UR - http://www.scopus.com/inward/record.url?scp=85109179113&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109179113&partnerID=8YFLogxK
U2 - 10.3390/metabo11070409
DO - 10.3390/metabo11070409
M3 - Review article
AN - SCOPUS:85109179113
SN - 2218-1989
VL - 11
JO - Metabolites
JF - Metabolites
IS - 7
M1 - 409
ER -